Speaker Profile

Ph.D., Vice President, Personalized Medicine, Sarah Cannon

Biography
Dr. McKenzie joined Sarah Cannon in 2015 and serves as the vice president of Sarah Cannon’s Personalized Medicine Program. He also serves as the scientific director for Genospace, Sarah Cannons precision medicine platform. McKenzie has more than 10 years of basic science and translational research experience in oncology. In his role, Dr. McKenzie is responsible for providing scientific and operational oversight for implementing Sarah Cannons personalized medicine strategy. He and the personalized medicine program provide scientific, consultative and programmatic services to clinical research investigators, study sponsors, research personnel and other healthcare providers to advance Sarah Cannons molecular profiling efforts. As scientific director at Genospace, McKenzie is responsible for providing scientific and strategic guidance to data science and product development activities. Prior to joining Sarah Cannon, Dr. McKenzie was a research fellow at Vanderbilt Universitys Vanderbilt-Ingram Cancer Center. He earned a Doctor of Philosophy in pharmacology from The University of Vermont.


 Session Abstract – PMWC 2023 Silicon Valley

Track 4 - January 26 9.00 A.M.-4.45 P.M.


Track Chair: Cindy Perettie, Roche

  • PMWC 2023 Award Ceremony
    - Luis Alberto Diaz Jr., MSK
    - Razelle Kurzrock, Medical College of Wisconsin
  • Non-invasive Liquid Biopsy Techniques (PANEL)
    Chair: Razelle Kurzrock, Medical College of Wisconsin
    - Apostolia Tsimberidou, MD Anderson
    - Mandana Kamgar, MD Medical College of Wisconsin
    - Mina Nikanjam, UCSD
    - Ash Alizadeh, Stanford University
  • Liquid Biopsy Challenges and Limitations (PANEL)
    Chair:
    - Luis Alberto Diaz Jr., MSK
    - Maximilian Diehn, Stanford
    - Dana Dilbeck, Agilent
  • Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL)
    Chair: Cindy Perettie, Roche Diagnostics
    - Andrew Mckenzie, Sarah Cannon
    - Cartl Barrett, Astra Zeneca
  • Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing
    Chair: Tom Beer, Excat Sceinces
  • Liquid Biopsy for Early Cancer Detection (PANEL)
    Chair: Priti Hegde, Foundation Medicine
    - Daniel Kim, UCSC
    - Mike Nolan, Freenome
    - Jeffrey Venstrom, Grail Bio
    - Kathryn Phillips, UCSF
    - Lon Castle, eviCore healthcare
  • Liquid Biopsy for Minimal Residual Disease (PANEL)
    Chair: Minetta Liu, Natera
    - Peter Bach, Delfi diagnostics
    - Laura Vantveer, UCSF
    - Nitin Sood, Adaptive
  • PMWC Showcase
    - Harmeet Dhani, Biological Dynamics
    - Varsha Rao, Claret Bio
  • PMWC NCI Showcase
    - Xianghong Jasmine Zhou, EarlyDiagnostics